Sec Form 3 Filing - Jones Michael Gwynne @ Science Strategic Acquisition Corp. Alpha - 2021-01-25

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Jones Michael Gwynne 2. Issuer Name and Ticker or Trading Symbol Science Strategic Acquisition Corp. Alpha [ SSAA] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) CEO (Last) (First) (Middle) C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET 3. Date of Earliest Transaction (MM/DD/YY) 01/25/2021 (Street) SANTA MONICA, CA90401 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Class B Common Stock, par value $0.0001 per share ( 1 ) ( 1 ) ( 1 ) Class A Common Stock, par value $0.0001 per share 5,487,000 D ( 2 ) ( 3 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Jones Michael Gwynne C/O SCIENCE STRATEGIC ACQUISITION CORP. 1447 2ND STREET SANTA MONICA, CA90401 X CEO Dare Tom C/O SCIENCE STRATEGIC ACQUISITION CORP. 1447 2ND STREET SANTA MONICA, CA90401 CFO Gilman Greg C/O SCIENCE STRATEGIC ACQUISITION CORP. 1447 2ND STREET SANTA MONICA, CA90401 X Pham Peter C/O SCIENCE STRATEGIC ACQUISITION CORP. 1447 2ND STREET SANTA MONICA, CA90401 President Signatures /s/ Andrew P. Campbell as attorney-in-fact for Michael Jones 01/25/2021 Signature of Reporting Person Date /s/ Andrew P. Campbell as attorney-in-fact for Thomas Dare 01/25/2021 Signature of Reporting Person Date /s/ Andrew P. Campbell as attorney-in-fact for Greg Gilman 01/25/2021 Signature of Reporting Person Date /s/ Andrew P. Campbell as attorney-in-fact for Peter Pham 01/25/2021 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The reported securities have no expiration date and (i) are convertible into shares of Class A common stock, par value $0.0001 per share ("Class A Shares"), of the Issuer at any time at the option of the holder on a one-for-one basis and (ii) will automatically convert into Class B Shares at the time of the Issuer's initial business combination on a one-for-one basis, in each case, subject to adjustment as described under the heading "Description of Securities-Founder Shares" in the Issuer's registration statement on Form S-1 (File No. 333-251987). ( 2 )SSAC Alpha Soponsor LLC (the "Sponsor") directly owns 5,487,000 shares of Class B Shares, including 843,750 Class B Shares that are subject to forfeiture if the underwriter of the Issuer's initial public offering does not exercise in full an option granted to it to cover over-allotments. ( 3 )The managing member of the Sponsor is Science Partners Management, LLC ("Science"). Michael Jones, Peter Pham, Thomas Dare and Greg Gilman (the "Reporting Persons") share control over Science and therefore, indirectly, the Sponsor and, as a result, each may be deemed to beneficially own the securities reported herein. Each Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of such Reporting Person's pecuniary interest therein.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.